HC Wainwright Has Bullish Forecast for REGENXBIO Q1 Earnings
REGENXBIO Inc. (NASDAQ:RGNX – Free Report) – Analysts at HC Wainwright increased their Q1 2025 earnings estimates for shares of REGENXBIO in a note issued to investors on Monday, March 17th. HC Wainwright analyst Y. Chen now forecasts that the biotechnology company will post earnings of ($1.21) per share for the quarter, up from their […]
